These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6390737)

  • 1. The effect of 5-fluorocytosine on the temperature profile of Candida albicans.
    Lemos-Carolino M; Madeira-Lopes A
    Sabouraudia; 1984; 22(4):351-4. PubMed ID: 6390737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
    [No Abstract]   [Full Text] [Related]  

  • 3. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
    Rumler W; Heins S
    Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
    [No Abstract]   [Full Text] [Related]  

  • 4. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
    Whelan WL; Beneke ES; Rogers AL; Soll DR
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1078-81. PubMed ID: 7023383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of flucytosine on the germination of Candida albicans.
    Wain WH; Polak A
    Postgrad Med J; 1979 Sep; 55(647):671-3. PubMed ID: 392482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of 5-fluorocytosine.
    Diasio RB; Bennett JE; Myers CE
    Biochem Pharmacol; 1978 Mar; 27(5):703-7. PubMed ID: 350227
    [No Abstract]   [Full Text] [Related]  

  • 9. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
    Hamra LK; Pankiewicz IJ
    Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [C. albicans spontaneous mutations determining 5-fluorocytosine resistance].
    Pawlik B; Barylak J
    Med Dosw Mikrobiol; 1977; 29(4):301-7. PubMed ID: 340821
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Markie D; Kwon-Chung KJ
    Antimicrob Agents Chemother; 1986 May; 29(5):726-9. PubMed ID: 3524427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action mechanism of 5-fluorocytosine. IV. Morphological observation and development of the resistant cells].
    Arai T; Mikami Y; Kawada T; Masuda K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):257. PubMed ID: 765563
    [No Abstract]   [Full Text] [Related]  

  • 17. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Synergism between 5-fluorocytosine and polyene antibiotics.
    Polak A
    Pathol Microbiol (Basel); 1975; 42(4):234-5. PubMed ID: 778764
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 5-fluorocytosine on the blastospores and hyphae of Candida albicans.
    Polak A; Wain WH
    J Med Microbiol; 1979 Feb; 12(1):83-97. PubMed ID: 372535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes in yeasts as a result of the action of 5-fluorocytosine.
    Arai T; Mikami Y; Yokoyama K; Kawata T; Masuda K
    Antimicrob Agents Chemother; 1977 Aug; 12(2):255-60. PubMed ID: 332075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.